Vir Biotechnology, Inc. (NASDAQ:VIR) Q2 2025 Earnings Call Transcript
Operator: Hello. Welcome to Vir Biotechnology's Second Quarter 2025 Financial Results and Corporate Update Call. As a reminder, this conference call is being recorded.
Vir Biotechnology Inc. (VIR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 3,464,917 | $17,463,182 | +115% | 0% |
| 2. | OrbiMed Advisors Samuel Isaly | 2,380,715 | $11,998,804 | +6% | 0.3% |
| 3. | Ikarian Capital Neil Shahrestani | 1,068,062 | $5,383,032 | 1.03% | |
| 4. | Renaissance Technologies Jim Simons | 1,064,500 | $5,365,080 | -5% | 0.01% |
| 5. | Hudson Bay Capital Management Sander Gerber | 696,000 | $3,507,840 | +18% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.73 | 2,500 | $56,815.50 | 10,000 | 2023-03-01 | Filing | |
| $24.96 | 2,500 | $62,395.50 | 7,500 | 2023-01-05 | Filing | |
| $25.25 | 2,500 | $63,136.25 | 5,000 | 2023-01-04 | Filing | |
| $25.60 | 2,500 | $63,992.50 | 2,500 | 2023-01-03 | Filing | |
| $43.39 | 12 | $499.85 | 12 | 2021-11-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.05 | 466,242 | $2,819,784.99 | 15,621,369 | 2025-10-08 | Filing | |
| $5.60 | 72,133 | $404,153.99 | 16,087,611 | 2025-10-07 | Filing | |
| $5.69 | 73,955 | $420,641.25 | 16,159,744 | 2025-10-06 | Filing | |
| $5.56 | 450,342 | $2,501,784.91 | 16,233,699 | 2025-10-03 | Filing | |
| $5.84 | 22,000 | $128,396.40 | 1,232,391 | 2025-10-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,795 | $95,899 | 0% | |
| 2. | 1,640 | $9,364 | 0% |
News See All
Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2025 Earnings Call Transcript
Operator: Hello. Welcome to Vir Biotechnology's First Quarter 2025 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
10 Stocks Under $10 that Will Triple
As we delve into the discussion on stocks that will triple, we must shed light on the U.S.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2024 Earnings Call Transcript
Operator: Hello. Welcome to Vir Biotechnology’s Fourth Quarter and Full Year 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
Why These 15 Stocks Are Skyrocketing in 2025
The market has started to favor smaller companies in 2025, and stocks between $1 billion and $5 billion in market value are attracting renewed interest.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2024 Earnings Call Transcript
Operator: [Call starts abruptly] …Vir's Third Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q2 2024 Earnings Call Transcript
Operator: Hello. Welcome to Vir Biotechnology’s Second Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript
Operator: Hello. Welcome to Vir Biotechnology’s First Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript
Vir Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.86, expectations were $-1.14. Vir Biotechnology, Inc.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to Vir Biotechnology's Third Quarter 2023 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
Hedge Fund Resource Center Billionaire Hedge Funds
